With an affinity for IR-A close to that of insulin, IGF-2 can exert mitogenic effects [17], but can also result in clinically significant hypoglycemia, particularly when present in circulating levels 100 to 1000 times that of insulin [2]. Here, IGF2 is linked to Hypoglycemia.